The trademark application XDERAH was filed by Basilea Pharmaceutica International AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on July 2, 2020, and it was registered by office on October 10, 2020 without any oppositions.
The application was filed in German (English was selected as the second language).